Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Biotech
Vanda tackles Wegovy-driven vomiting, sparking race to ph. 3
With the trial linking tradipitant to reduced nausea and vomiting in Wegovy patients, the biotech is gearing up for a phase 3 trial in the setting.
Nick Paul Taylor
Nov 18, 2025 10:44am
Zealand pumps brakes on development of dual GLP-1/GLP-2 agonist
Nov 13, 2025 9:52am
Novo CEO tells Pfizer to 'bid higher' if it wants to win Metsera
Nov 7, 2025 10:00am
Terns mothballs obesity program after phase 2 data fall short
Oct 22, 2025 7:15am
Lilly pads oral GLP-1 case with pair of phase 3 diabetes wins
Oct 15, 2025 9:48am
Fractyl delivers data on its device for GLP-1 weight maintenance
Sep 30, 2025 12:10pm
